François‐Xavier Danlos
Harvard University(US)Inserm(FR)Université Paris-Saclay(FR)Institut Gustave Roussy(FR)Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Occupational and environmental lung diseases, Pleural and Pulmonary Diseases, Medical Imaging and Pathology Studies, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study(2019)307 cited
- → Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease(2018)307 cited
- → A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers(2023)195 cited
- → Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma(2016)168 cited
- → Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers(2021)165 cited
- → Applications of single-cell and bulk RNA sequencing in onco-immunology(2021)156 cited